Li QB - Search Results

1

Mefunidone ameliorates lipopolysaccharide-induced acute lung injury through inhibiting MAPK signaling pathway and enhancing Nrf2 pathway.

Yao TT, Zhang Y, He RL, Lv X, He YJ, Li MY, Han YY, Long LZ, Jiang GL, Cheng XY, Hu GY, Li QB, Tao LJ, Meng J. Yao TT, et al. Among authors: li qb, li my. Int Immunopharmacol. 2022 Dec;113(Pt A):109263. doi: 10.1016/j.intimp.2022.109263. Epub 2022 Nov 2. Int Immunopharmacol. 2022. PMID: 36334370 Free article.

2

Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation.

Li Q, Fang H, Wang X, Hu G, Wang Q, Xu W. Li Q, et al. Bioorg Med Chem Lett. 2012 Jan 15;22(2):850-3. doi: 10.1016/j.bmcl.2011.12.048. Epub 2011 Dec 16. Bioorg Med Chem Lett. 2012. PMID: 22206607

3

Synthesis, pharmacokinetics, and pharmacodynamics studies of valsartan peptide derivatives.

Wu C, Hu Y, Li Q, He L, Chen J, Cheng Z, Li Y, Hu G. Wu C, et al. Arch Pharm (Weinheim). 2012 May;345(5):393-400. doi: 10.1002/ardp.201100377. Epub 2012 Jan 20. Arch Pharm (Weinheim). 2012. PMID: 22266917

4

Design, synthesis and anti-fibrosis activity study of N₁-substituted phenylhydroquinolinone derivatives.

Wu L, Liu B, Li Q, Chen J, Tao L, Hu G. Wu L, et al. Molecules. 2012 Feb 2;17(2):1373-87. doi: 10.3390/molecules17021373. Molecules. 2012. PMID: 22301723 Free PMC article.

5

Synthesis and structure-activity relationship of 5-substituent-2(1H)-pyridone derivatives as anti-fibrosis agents.

Chen J, Lu MM, Liu B, Chen Z, Li QB, Tao LJ, Hu GY. Chen J, et al. Among authors: li qb. Bioorg Med Chem Lett. 2012 Mar 15;22(6):2300-2. doi: 10.1016/j.bmcl.2012.01.073. Epub 2012 Jan 28. Bioorg Med Chem Lett. 2012. PMID: 22342629

6

Synthesis, pharmacophores, and mechanism study of pyridin-2(1H)-one derivatives as regulators of translation initiation factor 3A.

Zhu W, Shen J, Li Q, Pei Q, Chen J, Chen Z, Liu Z, Hu G. Zhu W, et al. Arch Pharm (Weinheim). 2013 Sep;346(9):654-66. doi: 10.1002/ardp.201300138. Epub 2013 Aug 19. Arch Pharm (Weinheim). 2013. PMID: 23959654

7

Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.

Lv M, Chen Z, Hu G, Li Q. Lv M, et al. Drug Discov Today. 2015 Mar;20(3):332-46. doi: 10.1016/j.drudis.2014.10.007. Epub 2014 Oct 31. Drug Discov Today. 2015. PMID: 25448752 Review.

8

The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.

Yu Z, Ye S, Hu G, Lv M, Tu Z, Zhou K, Li Q. Yu Z, et al. Future Med Chem. 2015;7(3):269-89. doi: 10.4155/fmc.14.143. Future Med Chem. 2015. PMID: 25826360 Review.

9

[Research progress of p70 ribosomal protein S6 kinase inhibitors].

Tu ZJ, Hu GY, Li QB. Tu ZJ, et al. Among authors: li qb. Yao Xue Xue Bao. 2015 Mar;50(3):261-71. Yao Xue Xue Bao. 2015. PMID: 26118103 Review. Chinese.

10

Inhibitors of 11β-Hydroxylase (CYP11B1) for Treating Diseases Related to Excess Cortisol.

Zhu W, Chen Z, Li Q, Tan G, Hu G. Zhu W, et al. Curr Med Chem. 2016;23(6):623-33. doi: 10.2174/0929867323666160122114947. Curr Med Chem. 2016. PMID: 26795197 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters